Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

How Low to Go: Details Emerge on Big Blood Pressure Study

November 10, 2015 11:40 am | by Marilynn Marchione, AP Medical Writer | News | Comments

Details were revealed Monday from a landmark federal study that challenges decades of thinking on blood pressure, giving a clearer picture of plusses and minuses of more aggressive treatment. Read more...


New Technique Could Expand Number of Diseases Detected by Noninvasive Prenatal Testing

November 10, 2015 11:27 am | by UC San Diego | News | Comments

Researchers at the University of California, San Diego School of Medicine developed a method to expand the types of chromosomal abnormalities that noninvasive prenatal testing (NIPT) can detect. Read more...


AHA 2015: Novo Nordisk's Diabetes Drug Has No Benefit Treating Heart Failure

November 10, 2015 11:07 am | by Ryan Bushey, Associate Editor | News | Comments

There was no significant difference shown between Victoza and a placebo in postponing hospitalization or death. Read more...


Amgen’s Biosimilar Equivalent to Humira in Phase 3 Study

November 10, 2015 10:35 am | by Stephanie Guzowski, Editor | News | Comments

Results from a head-to-head Phase 3 trial comparing Amgen’s biosimilar candidate ABP 501 to AbbVie’s Humira (adalimumab) in patients with moderate-to-severe rheumatoid arthritis (RA) has shown that ABP 501 demonstrated clinical equivalence with Humira.  Read more...


Ex-Duke Doctor’s Cancer Research Fraud Ends with 5 Years of Supervision

November 10, 2015 10:34 am | by Seth Augenstein, Digital Reporter | News | Comments

A Duke researcher manipulated data to verify his hypotheses in cancer research, according to a finding by the U.S. Office of Research Integrity. The finding, published Monday in the Federal Register, brings to an end more than five years of investigation into the work of Anil Potti, called by some the biggest medical fraud in history. Read more...


44,000-Patient Analysis Reinforces Safety, Effectiveness of Pradaxa

November 10, 2015 9:43 am | News | Comments

Brigham and Women's Hospital in Boston and Boehringer Ingelheim today announced the results of a new interim analysis from a long-term study evaluating the safety and effectiveness of Pradaxa (dabigatran etexilate mesylate) relative to warfarin in routine clinical practice. Read more...


China Starts Pilot Program to Improve Drug Approval Process

November 10, 2015 8:15 am | by Ryan Bushey, Associate Editor | News | Comments

The country is hoping this plan pays off in two different ways. Read more...


Russia Faces Olympic Ban after Hugely Critical Doping Report

November 10, 2015 8:00 am | by John Leicester and Graham Dunbar, AP Sports Writers | News | Comments

Russian track and field athletes could be banned from next year's Olympics in Rio de Janeiro after a devastatingly critical report accused the country's government of complicity in widespread doping and cover-ups. Read more...


Relapsing Infections Could Challenge Malaria Eradication

November 10, 2015 7:45 am | by Walter + Eliza Hall Research Institute | News | Comments

The discovery has significant repercussions for the country’s – and region’s – malaria control program. Read more...


HIV Scientists Launch £17M Project to Develop Vaccine

November 10, 2015 7:30 am | by University of Oxford | News | Comments

At Oxford, researchers will be looking at raising two specific types of immunity to HIV infection. Read more...


FDA Gives Breakthrough Designation to Teva's Tardive Dyskinesia Drug

November 10, 2015 7:15 am | News | Comments

Tardive dyskinesia has been described as a condition characterized by repetitive and uncontrollable movements of the tongue, lips, face, and extremities. Read more...


Sierra Leone Declared Free of Ebola, as Guinea Struggles

November 10, 2015 7:00 am | by Clarence Roy-Macaulay, Associated Press | News | Comments

Cheers erupted and people danced in the streets Saturday as Sierra Leone marked the end of the Ebola outbreak within its borders. Read more...


Diabetes Drug Reduces Risk of Heart Failure and May Prevent It, Study Shows

November 9, 2015 11:55 am | by Yale University | News | Comments

For the first time, research shows that a type 2 diabetes drug significantly reduces hospitalizations and death from heart failure. Read more...


Sanofi, Lilly Highlight RA Results at ACR

November 9, 2015 11:42 am | by Stephanie Guzowski, Editor | News | Comments

Sanofi and Eli Lilly both announced phase 3 data on rheumatoid arthritis investigational therapies this weekend at the American College of Rheumatology annual meeting in San Francisco. Read more...


FDA Panel Calls for Better Label Warnings for Well-Known Antibiotics

November 9, 2015 10:33 am | by Ryan Bushey, Associate Editor | News | Comments

The panel made the decision after hearing testimony from patients who have taken these drugs and dealt with a wide variety of side effects. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.